# A Study of TAK-951 in Healthy Adults

> **NCT06610279** · PHASE1 · TERMINATED · sponsor: **Takeda** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-951
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06610279
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-07
- **Primary completion:** 2023-09-21
- **Final completion:** 2023-09-21
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** The study was terminated based on the Sponsor's decision attributed to the benefit-risk profile derived from the Part 1 data of this study.
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06610279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06610279, "A Study of TAK-951 in Healthy Adults". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06610279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*